Logo

Ami Organics Share Price

NSE: ACUTAAS
|
Pharmaceuticals
₹ 3,694.80
+₹3.00 (0.08%)
1D
Last updated 03 Jul, 2026, 15:57 IST

Ami Organics Share Price Today

As of 5 Jul 2026, Ami Organics share price is ₹3,694.80. The stock opened at ₹3,709.00, compared to its previous close of ₹3,691.80. During today's trading session, Ami Organics share price moved in the range of ₹3,656.10 to ₹3,730.90, with an average price of ₹3,693.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,095.40 and a high of ₹3,730.90. On the performance front, Ami Organics share price has increased by 111.22% over the last six months and is up 235.68% on a year-on-year basis.


₹3,656.10
0.08% up today
₹3,730.90
1D LOW
1D HIGH

Ami Organics Returns Calculator

Open
₹3,709.00
High
₹3,730.90
Low
₹3,656.10
Prev. close
₹3,691.80

Circuit
L
H
₹2,955.90
₹4,433.70
52-week
L
H
₹1,095.40
₹3,730.90

Ami Organics Shareholder Returns

Ami Organics Share Price History

Mkt Cap Cr
30,211.70

P/E
84.77

P/B
18.27

ROE
21.54%

D/E
0.02

ROCE
28.77%

Div. Yield
0.07%

EPS(TTM)
44.73
Turnover
0.77

EV/EBITDA
55.59

Net Margin
0.00%

Op. Margin
0.00%

ROA
17.96%

Quick Ratio
0.00

Curr. Ratio
4.05
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Acutaas Chemical outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Acutaas Chemical appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Acutaas Chemical revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Ami Organics Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,006.88₹717.47₹616.73₹520.14
Other Income₹16.93₹7.49₹4.32₹2.76
Total Revenue₹1,023.80₹724.97₹621.05₹522.90
Total Expenses₹807.64₹610.98₹508.88₹431.45
Profit Before Tax₹216.16₹81.90₹112.17₹91.45
Tax₹55.75₹33.19₹28.88₹19.50
Profit After Tax₹160.42₹48.71₹83.29₹71.95
EPS - Basic₹19.91₹5.96₹22.86₹21.03
EPS - Diluted₹19.91₹5.95₹22.86₹21.03

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹216.16₹81.90₹112.17₹91.45
Income before WC changes₹235.09₹131.69₹126.27₹105.09
Change in Assets-₹101.04-₹32.51-₹67.33-₹118.29
Change in Liabilities₹31.03₹50.33₹31.05₹24.07
Change in WC-₹70.01₹17.82-₹36.28-₹94.21
Cash flow from Operations₹118.34₹125.17₹65.53-₹11.93
Cash flow from Investing-₹223.94-₹365.39-₹33.04-₹120.72
Cash flow from Financing₹261.12₹239.36-₹12.25₹140.26
Total Cash Flow₹155.52-₹0.86₹20.24₹7.61
Cash (Start of the year)₹29.70₹30.53₹10.30₹2.68
Cash (End of the year)₹185.22₹29.70₹30.53₹10.30

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹757.63₹602.60₹309.81₹229.31
Current Assets₹791.64₹493.30₹457.13₹429.57
Total Assets₹1,549.26₹1,095.90₹766.94₹658.88
Current Liabilities₹202.25₹285.17₹162.85₹129.32
Net Current Asset₹589.39₹208.13₹294.28₹300.25
Non-Current Liabilities₹26.93₹127.98₹10.13₹7.29
Equity Capital₹1,320.08₹682.76₹593.96₹522.27
Total Equity & Liabilities₹1,549.26₹1,095.90₹766.94₹658.88

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹989.83₹687.58₹616.73₹520.14
Other Income₹18.34₹13.79₹4.32₹2.76
Total Revenue₹1,008.17₹701.37₹621.05₹522.90
Total Expenses₹794.59₹600.51₹508.83₹431.45
Profit Before Tax₹213.58₹69.11₹112.22₹91.45
Tax₹54.03₹25.42₹28.88₹19.50
Profit After Tax₹159.55₹43.68₹83.34₹71.95
EPS - Basic₹19.91₹5.96₹22.87₹21.03
EPS - Diluted₹19.91₹5.95₹22.87₹21.03

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹213.58₹69.11₹112.22₹91.45
Income before WC changes₹228.18₹110.95₹123.42₹103.81
Change in Assets-₹101.28-₹41.79-₹73.65-₹114.75
Change in Liabilities₹32.74₹47.81₹30.42₹24.07
Change in WC-₹68.54₹6.02-₹43.23-₹90.68
Cash flow from Operations₹115.93₹100.85₹55.73-₹9.69
Cash flow from Investing-₹234.37-₹337.35-₹20.47-₹122.47
Cash flow from Financing₹273.56₹235.48-₹14.44₹140.26
Total Cash Flow₹155.12-₹1.02₹20.82₹8.10
Cash (Start of the year)₹29.49₹30.48₹9.66₹1.56
Cash (End of the year)₹184.61₹29.49₹30.48₹9.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹766.64₹603.44₹304.75₹227.90
Current Assets₹771.31₹467.81₹454.71₹426.71
Total Assets₹1,537.95₹1,071.25₹759.46₹654.61
Current Liabilities₹199.04₹267.84₹162.78₹129.31
Net Current Asset₹572.27₹199.97₹291.93₹297.39
Non-Current Liabilities₹27.32₹128.29₹9.89₹7.29
Equity Capital₹1,311.60₹675.12₹586.79₹518.00
Total Equity & Liabilities₹1,537.95₹1,071.25₹759.46₹654.61
* All values are in INR Crore
Qty
Bid
24
3694.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 24
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
75.89
Bullish

ATR (14)
134.99
Neutral

STOCH(9,6)
93.56
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
52.46
Bearish

UO(9)
68.74
Neutral

ROC(12)
23.3
Bullish

WillR(14)
-4.68
Bearish
Period
Simple value
Exponential vaue

5D
3609.7
3592.14

10D
3439.01
3474

20D
3297.15
3327.36

50D
2989.81
3030.98

100D
2603.11
2705.9

About Ami Organics

Ami Organics logo
ISIN
INE00FF01025
Sector Market Cap
₹ 30,211.7 Cr

Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

Ami Organics Financial Highlights

  • Revenue: Ami Organics reported revenue of ₹1,380.96 crore in FY26 vs ₹1,023.81 crore in FY25. It showed an increase of 34.88% on a yearly basis.
  • Operating Profit: Ami Organics reported an operating profit of ₹482.73 crore in FY26 vs ₹216.16 crore in FY25. It showed an increase of 123.32% on a year-on-year basis.
  • Net Profit: Ami Organics reported a net profit of ₹356.37 crore in FY26 vs ₹160.42 crore in FY25. It showed an increase of 122.15% on a yearly basis.

Ami Organics Quarterly Result Highlights

  • Ami Organics reported revenue of ₹443.86 crore in Mar 2026, compared with ₹397.88 crore in Dec 2025, representing an increase of 11.56% on a quarter-on-quarter (QoQ) basis.
  • Ami Organics reported an operating profit of ₹183.80 crore in Mar 2026, compared with ₹144.67 crore in Dec 2025, representing an increase of 27.05% on a quarter-on-quarter (QoQ) basis.
  • Ami Organics reported a profit of ₹134.28 crore in Mar 2026, compared with ₹106.22 crore in Dec 2025, reflecting an increase of 26.42% on a QoQ basis.
  • The earnings per share (EPS) of Ami Organics stood at ₹19.91 during Mar 2026.
Know more
Promoters
32.66%
FII
19.48%
Other DII
5.74%
Retail and other
28.25%
Mutual funds
13.86%
Foreign institutions - FII
Compare against other stocks
Ami Organics logo
Ami Organics
Pharmaceuticals
Add Stock
Add Another

FAQs on Ami Organics Share Price